CEO Says “5,000% Price Hike On Daraprim Drug Not Excessive”

[by Howard Fencl, Hennes Communications] Rarely do we see such a bracing, breathtaking display of contradictory messages and corporate spin as in the case of Turing Pharmaceutical’s 5,000 percent price hike of the toxoplasmosis drug, Daraprim. Toxoplasmosis is a parasitic disease that can kill people with compromised immune systems. Daraprim, once $13.50 per pill, was […]